2012-01-09T09:18:20Z
2012-01-09T09:18:20Z
2011
2011-12-27T14:10:22Z
Podeu consultar el llibre complet a: http://www.trnres.com/ebookcontents.php?id=149
The aim of this work was to design a novel strategy to detect new targets for anticancer treatments. The rationale was to build Biological Association Networks from differentially expressed genes in drug-resistant cells to identify important nodes within the Networks. These nodes may represent putative targets to attack in cancer therapy, as a way to destabilize the gene network developed by the resistant cells to escape from the drug pressure. As a model we used cells resistant to methotrexate (MTX), an inhibitor of DHFR. Selected node-genes were analyzed at the transcriptional level and from a genotypic point of view. In colon cancer cells, DHFR, the AKR1 family, PKC¿, S100A4, DKK1, and CAV1 were overexpressed while E-cadherin was lost. In breast cancer cells, the UGT1A family was overexpressed, whereas EEF1A1 was overexpressed in pancreatic cells. Interference RNAs directed against these targets sensitized cells towards MTX.
Chapter or part of a book
Published version
English
Càncer; Quimioteràpia; Farmacogenètica; Cancer; Chemotherapy; Pharmacogenetics
Transworld Research Network
Reproducció del capítol 1 del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=106
Recent Advances in Pharmaceutical Sciences, 2011, Chapter 1, p. 1-33. Editor: Diego Muñoz-Torrero
http://hdl.handle.net/2445/32392
(c) Transworld Research Network, 2011